Tag Archives: Sanofi Prepares Governance Changes Ahead of April 2026 Annual General Meeting with Proposed Board Appointment

Sanofi Board Proposes Appointment of Orange CEO Christel Heydemann as Independent Director at April 2026 Shareholder Meeting

(IN BRIEF) Sanofi announced that its Board of Directors will propose the appointment of Orange CEO Christel Heydemann as an independent director during the company’s Annual General Meeting scheduled for April 29, 2026. At the same meeting, shareholders will also … Read the full press release